| 摘要 |
Use of 10-aminoaliphatyl-dibenzÄb,fÜ oxepine cpds. of formula (I) and their salts in the prepn. of a medicament for the treatment of neurodegenerative disorders is new. Alk = a divalent aliphatic residue; R = amino (opt. substd. by 1-2 monovalent aliphatic and/or araliphatic residues, or opt. substd. by a divalent aliphatic residue); R1-R4 = H, T, TO, halo or CF3; T = lower alkyl; (I) are new, with provisos. |
